MY109640A - Antitumor compositions and methods of treatment - Google Patents

Antitumor compositions and methods of treatment

Info

Publication number
MY109640A
MY109640A MYPI93000160A MYPI19930160A MY109640A MY 109640 A MY109640 A MY 109640A MY PI93000160 A MYPI93000160 A MY PI93000160A MY PI19930160 A MYPI19930160 A MY PI19930160A MY 109640 A MY109640 A MY 109640A
Authority
MY
Malaysia
Prior art keywords
treatment
methods
antitumor compositions
antitumor
compositions
Prior art date
Application number
MYPI93000160A
Inventor
Burr Grindey Gerald
Joseph Ehlhardt William
Eldon Toth John
Bernard Boder George
Frederick Worzalla John
Lyle Zimmermann John
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MY109640A publication Critical patent/MY109640A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Undergarments, Swaddling Clothes, Handkerchiefs Or Underwear Materials (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

THIS INVENTION PROVIDES THE US OF N-[[(3, 4-DICHLOROPHENYL) AMINO] CARBONYL]-2, 3-DIHYDROBENZOFURAN-5-SULFONAMIDE, AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, IN THE TREATMENT OF SUSCEPTIBLE NEOPLASMS IN MAMMALS. THIS INVENTION FURTHER PROVIDES THE NOVEL AFOREMENTIONED COMPOUND AND ITS PHARMACEUTICAL FORMULATIONS.
MYPI93000160A 1992-02-05 1993-02-02 Antitumor compositions and methods of treatment MY109640A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/831,604 US5254582A (en) 1992-02-05 1992-02-05 Antitumor compositions and methods

Publications (1)

Publication Number Publication Date
MY109640A true MY109640A (en) 1997-03-31

Family

ID=25259448

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI93000160A MY109640A (en) 1992-02-05 1993-02-02 Antitumor compositions and methods of treatment

Country Status (25)

Country Link
US (1) US5254582A (en)
EP (1) EP0555036B1 (en)
JP (1) JP3210117B2 (en)
KR (1) KR100246148B1 (en)
CN (1) CN1044239C (en)
AT (1) ATE170853T1 (en)
AU (1) AU658043B2 (en)
BR (1) BR9300469A (en)
CA (1) CA2088719A1 (en)
CY (1) CY2101B1 (en)
CZ (1) CZ282753B6 (en)
DE (1) DE69320844T2 (en)
DK (1) DK0555036T3 (en)
ES (1) ES2121940T3 (en)
FI (1) FI930453A (en)
HU (2) HU213231B (en)
IL (1) IL104574A (en)
MX (1) MX9300558A (en)
MY (1) MY109640A (en)
NO (1) NO302472B1 (en)
NZ (1) NZ245818A (en)
RU (1) RU2072996C1 (en)
SG (1) SG79181A1 (en)
YU (1) YU48915B (en)
ZA (1) ZA93689B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116874A (en) * 1985-09-23 1992-05-26 Eli Lilly And Company Anti-tumor method and compounds
US5529999A (en) * 1994-03-04 1996-06-25 Eli Lilly And Company Antitumor compositions and methods of treatment
ATE208774T1 (en) * 1996-08-22 2001-11-15 Dong Wha Pharm Ind Co Ltd ARYLSULFONYLIMIDAZOLONE DERIVATIVES AS ANTI-TUMOR AGENTS
WO1998014440A1 (en) * 1996-10-04 1998-04-09 Eli Lilly And Company Antitumor compositions and methods of treatment
WO1998044799A1 (en) * 1997-04-10 1998-10-15 Eli Lilly And Company Diarylsulfonylureas for use in treating secretory diarrhea
US5932407A (en) * 1997-04-30 1999-08-03 Eastman Kodak Company Color photographic element containing oxidized developer-scavenging naphtholic coupler forming wash-out dye
BRPI0412219B8 (en) 2003-07-23 2021-07-27 Bayer Healthcare Llc fluoro substituted omega-carboxy aryl diphenyl urea compounds and pharmaceutical compositions comprising said compounds
JP5134247B2 (en) * 2004-09-13 2013-01-30 エーザイ・アール・アンド・ディー・マネジメント株式会社 Combination of sulfonamide-containing compounds with angiogenesis inhibitors
EP2364699A1 (en) 2004-09-13 2011-09-14 Eisai R&D Management Co., Ltd. Joint use of sulfonamide based compound with angiogenesis inhibitor
US8772269B2 (en) 2004-09-13 2014-07-08 Eisai R&D Management Co., Ltd. Use of sulfonamide-including compounds in combination with angiogenesis inhibitors
JPWO2007123274A1 (en) 2006-04-20 2009-09-10 エーザイ・アール・アンド・ディー・マネジメント株式会社 Novel sensitivity markers for sulfonamide compounds
CN104941647B (en) * 2015-06-18 2017-07-04 四川之江高新材料股份有限公司 Synthesize the method and loaded catalyst used of N methyl morpholines

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3083207A (en) * 1963-03-26 Indolinesulfonylureas
US1208561A (en) * 1914-09-14 1916-12-12 Stephen E Huff Sound-box attachment for phonographs.
US3097242A (en) * 1960-06-29 1963-07-09 Olin Mathieson Hydrindene sulfonylureas
US3102121A (en) * 1961-06-29 1963-08-27 Olin Mathieson Novel cumaransulfonylureas and 2,3-dihydrothionaphthenesulfonylureas
NL295122A (en) * 1962-04-11
US3849110A (en) * 1963-01-07 1974-11-19 Lilly Co Eli Herbicidal method employing aryl-sulfonylureas or salts thereof
US3736122A (en) * 1969-04-10 1973-05-29 C Tung Method of controlling plant growth
AU1862083A (en) * 1982-09-02 1984-03-08 Duphar International Research B.V. Tumor growth inhibitors
CA1208561A (en) * 1984-01-19 1986-07-29 Marius S. Brouwer Pharmaceutical compositions containing benzoylurea compounds
US4845128A (en) * 1984-06-27 1989-07-04 Eli Lilly And Company N([(4-trifluoromethylphenyl)amino]carbonyl)benzene sulfonamides
JPS6163671A (en) * 1984-09-05 1986-04-01 Shionogi & Co Ltd 2,3-dihydrobenzofuran-5-sulfonamide derivative and hypotensive diuretic
US5116874A (en) * 1985-09-23 1992-05-26 Eli Lilly And Company Anti-tumor method and compounds
GR862353B (en) * 1985-09-23 1987-01-19 Lilly Co Eli Anti-tumor method and compounds
CA1331464C (en) * 1987-05-12 1994-08-16 Eli Lilly And Company Anti-tumor method and compounds
NZ238911A (en) * 1990-07-17 1993-10-26 Lilly Co Eli Furyl, pyrrolyl and thienyl sulphonyl urea derivatives, pharmaceutical compositions and intermediates therefor
US5169860A (en) * 1992-03-13 1992-12-08 Eli Lilly And Company Antitumor compositions and methods of treatment

Also Published As

Publication number Publication date
HUT63842A (en) 1993-10-28
YU5893A (en) 1996-07-24
EP0555036A2 (en) 1993-08-11
CN1044239C (en) 1999-07-21
NO930380D0 (en) 1993-02-03
NZ245818A (en) 1995-03-28
NO302472B1 (en) 1998-03-09
CZ282753B6 (en) 1997-09-17
DK0555036T3 (en) 1999-06-07
NO930380L (en) 1993-08-06
SG79181A1 (en) 2001-03-20
DE69320844D1 (en) 1998-10-15
IL104574A0 (en) 1993-06-10
ZA93689B (en) 1994-08-01
KR100246148B1 (en) 2000-04-01
AU3218393A (en) 1993-08-12
YU48915B (en) 2002-11-15
JPH05306277A (en) 1993-11-19
ATE170853T1 (en) 1998-09-15
BR9300469A (en) 1993-08-10
FI930453A0 (en) 1993-02-02
HU9300288D0 (en) 1993-04-28
AU658043B2 (en) 1995-03-30
CY2101B1 (en) 2002-04-05
HU213231B (en) 1997-03-28
HU211561A9 (en) 1995-12-28
CA2088719A1 (en) 1993-08-06
EP0555036B1 (en) 1998-09-09
IL104574A (en) 1997-02-18
KR930017885A (en) 1993-09-20
FI930453A (en) 1993-08-06
DE69320844T2 (en) 1999-03-04
ES2121940T3 (en) 1998-12-16
EP0555036A3 (en) 1993-11-24
US5254582A (en) 1993-10-19
CN1075961A (en) 1993-09-08
CZ12093A3 (en) 1993-12-15
RU2072996C1 (en) 1997-02-10
JP3210117B2 (en) 2001-09-17
MX9300558A (en) 1993-08-01

Similar Documents

Publication Publication Date Title
CA2137203A1 (en) Protein kinase c inhibitors
CA2216535A1 (en) Protein kinase c inhibitors
IL127244A (en) Substituted amines, methods of their preparation and pharmaceutical compositions containing them
UA39158C2 (en) derivatives of N4-oxycarbonyl- 5'-deoxy-5-fluorocytidine and pharmaceutical preparation based thereon
CA2237221A1 (en) Protein kinase c inhibitor
HK1024177A1 (en) Cytotoxic amino sugar and related sugar derivatives of indolopyrrolocarbazoles
MY109640A (en) Antitumor compositions and methods of treatment
IL101358A0 (en) Crystalline tiagabine hydrochloride monohydrate,its preparation and pharmaceutical compositions containing it
RU93004535A (en) COMPOUNDS, METHOD OF OBTAINING AND PHARMACEUTICAL COMPOSITION ON THEIR BASIS
MY118175A (en) Crystalline pharmaceutical product
GEP20032975B (en) Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition
IL110780A0 (en) Pharmaceutical compositions containing 1,3-bis(2-carboxy-chromon-5-yloxy)-propan-2-ol for the treatment of the common cold
HUP9802536A3 (en) Pharmaceutical compositions containing 1,2,4-benzotriazine 1,4-dioxide and use thereof for the preparation of pharmaceutical compositions treating cancer
MY118946A (en) Novel intermediates and their use to prepare n, n''- bridged bisindolylmaleimides
TH9193B (en) Anti-tumor mixtures and methods of their treatment
TH13149A (en) Anti-tumor mixtures and methods of their treatment
TH13149EX (en) Anti-tumor mixtures and methods of their treatment